IP Library Granted Patent US 8,022,032
Granted Patent B2
US 8,022,032 · App. 11/718,154 · Granted Sep 20, 2011

Method for customized dispensing of variable dose drug combination products for individualizing of therapies

Assignee: SmithKline Beecham Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,022,032
App. No.
11/718,154
Granted
Sep 20, 2011
Kind
B2
Abstract

The method set out herein involves identifying the concentration of each of two or more active therapeutics tailored to treat a particular patient's unique metabolism and one or more diseases, communicating that information to a producer who has multiple fixed or variable concentrations of each active available, where the producer then combines the individual concentrations of each active into single units such as a tablets or pills, and distributes those indirectly or directly to the patient.

Claims (16)

1. A method, comprising:

a) preparing each of a plurality of formulations in a corresponding physical form, each of said physical forms having a concentration of an active agent;

b) stockpiling said physical forms with a group which has the capacity to combine a plurality of said physical forms into a single unit;

c) identifying two or more of said physical forms to treat a patient;

d) communicating the physical forms identified in step (c) to said group stockpiling said physical forms;

e) wherein said group combines said physical forms identified in step (c) into a single unit; and

f) distributing said single unit indirectly or directly to the patient.

2. A method, comprising:

a) preparing each of a plurality of formulations in a corresponding physical form, each of said physical forms having a concentration of an active agent;

b) stockpiling said physical forms;

c) identifying two or more of said physical forms to treat a patient;

d) communicating said two or more physical forms identified in step (c) to said group stockpiling said physical forms;

e) supplying said two or more formulations identified in step (c) to a second group which combines said physical forms identified in step (c) into a single unit; and

f) distributing said single unit indirectly or directly to the patient.

3. The method of claim 1 , wherein said physical form is a solid.

4. The method of claim 2 , wherein said physical form is a solid.

Assignments (2)
CHANGE OF NAME Recorded Feb 3, 2011
From: SMITHKLINE BEECHAM CORPORATION
To: GLAXOSMITHKLINE LLC
Reel/Frame 025741/0808 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 1, 2007
From: MARTINI, LUIGI; KIRSH, RICHARD L.; FINKELMEIER, STEVEN D.; GLINECKE, ROBERT
To: SMITHKLINE BEECHAM CORPORATION
Reel/Frame 019229/0281 →
Continuity (2)
Continuation 60629876 · Nov 19, 2004
Related Publication 20090149507A1 · Jun 11, 2009